Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Application of combined omics platforms to accelerate biomedical discovery in diabesity.

Kurland IJ, Accili D, Burant C, Fischer SM, Kahn BB, Newgard CB, Ramagiri S, Ronnett GV, Ryals JA, Sanders M, Shambaugh J, Shockcor J, Gross SS.

Ann N Y Acad Sci. 2013 May;1287:1-16. doi: 10.1111/nyas.12116. Epub 2013 May 9.

2.

Impaired glucose homeostasis in non-diabetic Greek hypertensives with diabetes family history. Effect of the obesity status.

Vyssoulis GP, Liakos CI, Karpanou EA, Triantafyllou AI, Michaelides AP, Tzamou VE, Markou MI, Stefanadis CI.

J Am Soc Hypertens. 2013 Jul-Aug;7(4):294-304. doi: 10.1016/j.jash.2013.02.007. Epub 2013 Apr 3.

PMID:
23562108
3.

Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes.

Hagberg CE, Mehlem A, Falkevall A, Muhl L, Fam BC, Ortsäter H, Scotney P, Nyqvist D, Samén E, Lu L, Stone-Elander S, Proietto J, Andrikopoulos S, Sjöholm A, Nash A, Eriksson U.

Nature. 2012 Oct 18;490(7420):426-30. doi: 10.1038/nature11464. Epub 2012 Sep 26.

PMID:
23023133
4.

Islet function in obese adolescents.

Giannini C, Caprio S.

Diabetes Obes Metab. 2012 Oct;14 Suppl 3:40-5. doi: 10.1111/j.1463-1326.2012.01643.x. Review.

PMID:
22928563
5.

[Correlation between insulin resistance and puberty in children with increased cardiometabolic risk].

Tobisch B, Blatniczky L, Barkai L.

Orv Hetil. 2011 Jul 3;152(27):1068-74. doi: 10.1556/OH.2011.29159. Hungarian.

PMID:
21676673
6.

From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation.

Bacha F, Lee S, Gungor N, Arslanian SA.

Diabetes Care. 2010 Oct;33(10):2225-31. doi: 10.2337/dc10-0004. Epub 2010 Jun 30.

7.
8.

Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III.

Srikanthan P, Hevener AL, Karlamangla AS.

PLoS One. 2010 May 26;5(5):e10805. doi: 10.1371/journal.pone.0010805. Epub 2010 May 26.

9.

Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.

Holst-Schumacher I, Nuñez-Rivas H, Monge-Rojas R, Barrantes-Santamaría M.

Food Nutr Bull. 2009 Jun;30(2):161-70.

PMID:
19689095
10.

Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.

Vinciguerra F, Baratta R, Farina MG, Tita P, Padova G, Vigneri R, Frittitta L.

Acta Diabetol. 2013 Jun;50(3):443-9. doi: 10.1007/s00592-013-0460-3. Epub 2013 Feb 28.

PMID:
23447004
11.

Obesity and type 2 diabetes: which patients are at risk?

Garber AJ.

Diabetes Obes Metab. 2012 May;14(5):399-408. doi: 10.1111/j.1463-1326.2011.01536.x. Epub 2011 Dec 27. Review.

PMID:
22074144
12.

Insulin resistance and obesity.

Greenfield JR, Campbell LV.

Clin Dermatol. 2004 Jul-Aug;22(4):289-95. Review.

PMID:
15475228
13.

Vitamin A and Diabesity: New Insight for Drug Discovery.

Cione E, Caroleo MC, Cannataro R, Perri M, Pingitore A, Genchi G.

Mini Rev Med Chem. 2016;16(9):738-42. Review.

PMID:
26156540
14.

The prevalence of diabetes, pre-diabetes and the metabolic syndrome in an Irish regional homeless population.

Scott J, Gavin J, Egan AM, Avalos G, Dennedy MC, Bell M, Dunne F.

QJM. 2013 Jun;106(6):547-53. doi: 10.1093/qjmed/hct063. Epub 2013 Mar 27.

PMID:
23536367
15.

All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies.

Karmali R, Dalovisio A, Borgia JA, Venugopal P, Kim BW, Grant-Szymanski K, Hari P, Lazarus H.

Blood Rev. 2015 Mar;29(2):71-80. doi: 10.1016/j.blre.2014.09.010. Epub 2014 Sep 28. Review.

PMID:
25433571
17.

From hyperglycemia to the risk of cardiovascular disease.

Leiter LA.

Rev Cardiovasc Med. 2006;7 Suppl 2:S3-9. Review.

PMID:
17224875
18.

Are there healthy obese?

Griera Borrás JL, Contreras Gilbert J.

Endocrinol Nutr. 2014 Jan;61(1):47-51. doi: 10.1016/j.endonu.2013.03.010. Epub 2013 Oct 25. Review. English, Spanish.

PMID:
24210176
19.

The metabolic consequences of childhood obesity.

Weiss R, Caprio S.

Best Pract Res Clin Endocrinol Metab. 2005 Sep;19(3):405-19. Review.

PMID:
16150383
20.

MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics.

Deiuliis JA.

Int J Obes (Lond). 2016 Jan;40(1):88-101. doi: 10.1038/ijo.2015.170. Epub 2015 Aug 27. Review.

Supplemental Content

Support Center